DNA’s Q1 2025 financial report shows revenue reaching $2 million, a 15% increase year-on-year. Operating expenses are recorded at $1.2 million, up 10% due to increased investment in research and development (R&D). Gross profit stands at $800,000, resulting in a net profit of $300,000. The net profit margin remains at 15%. The company continues to expand its market and increase workforce to meet growing demand. Plans for the next quarter include expanding production capacity and launching new products. Management maintains its revenue forecast for 2025 at $10 million, reflecting a 25% growth compared to 2024.
Leave a Reply